GOLDMAN SACHS GROUP INC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 84 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$10,000
-95.8%
50,539
-90.4%
0.00%
Q3 2018$238,000
-76.4%
527,486
-73.7%
0.00%
Q2 2018$1,009,000
-6.1%
2,003,328
+333.9%
0.00%
Q1 2018$1,075,000
+30.3%
461,662
+58.9%
0.00%
Q4 2017$825,000
-24.5%
290,464
-23.9%
0.00%
Q3 2017$1,092,000
+103.4%
381,907
+75.5%
0.00%
Q2 2017$537,000
-46.9%
217,550
-22.4%
0.00%
Q1 2017$1,012,000
+2.8%
280,425
+0.9%
0.00%
Q4 2016$984,000
+14.7%
277,972
+30.9%
0.00%
Q3 2016$858,000
-54.7%
212,435
-50.7%
0.00%
-100.0%
Q2 2016$1,893,000
+11.2%
431,287
-4.3%
0.00%0.0%
Q1 2016$1,703,000
-63.7%
450,461
+50.5%
0.00%0.0%
Q4 2015$4,694,000
+75.2%
299,366
+17.8%
0.00%0.0%
Q3 2015$2,679,000
-80.0%
254,146
-52.1%
0.00%
-75.0%
Q2 2015$13,367,000
+53.3%
530,043
+69.5%
0.00%
+33.3%
Q1 2015$8,717,000
+41.1%
312,757
-7.6%
0.00%
+50.0%
Q4 2014$6,179,000
-2.1%
338,575
-30.5%
0.00%0.0%
Q3 2014$6,312,000
+73.2%
487,091
+118.1%
0.00%
+100.0%
Q2 2014$3,645,000
-11.0%
223,339
-3.6%
0.00%0.0%
Q1 2014$4,094,000
-48.3%
231,726
-29.1%
0.00%
-66.7%
Q4 2013$7,914,000
+3.2%
326,897
+51.0%
0.00%0.0%
Q3 2013$7,672,000
+285.7%
216,543
+70.0%
0.00%
+200.0%
Q2 2013$1,989,000
+680.0%
127,392
+235.8%
0.00%
Q4 2012$255,000
-76.5%
37,935
-77.9%
0.00%
Q3 2012$1,083,000
+296.7%
171,788
+225.8%
0.00%
Q2 2012$273,000
-45.1%
52,722
-46.0%
0.00%
Q1 2012$497,00097,6340.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2018
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders